Search details
1.
Exploration of the Impact of Combining Risk Phenotypes on the Likelihood of Alcohol Problems in Young Adults.
Alcohol Alcohol
; 57(3): 357-363, 2022 May 10.
Article
in English
| MEDLINE | ID: mdl-34272558
2.
A Randomized Controlled Trial of an Integrated Alcohol Reduction Intervention in Patients With Hepatitis C Infection.
Hepatology
; 71(6): 1894-1909, 2020 06.
Article
in English
| MEDLINE | ID: mdl-31803945
3.
Bupropion, Alone and in Combination with Naltrexone, Blunts Binge-Like Ethanol Drinking and Intake Following Chronic Intermittent Access to Ethanol in Male C57BL/6J Mice.
Alcohol Clin Exp Res
; 43(5): 783-790, 2019 05.
Article
in English
| MEDLINE | ID: mdl-30817015
4.
Approval of Baclofen for Alcohol Use Disorders in France: A Perspective From the United States.
Alcohol Alcohol
; 55(1): 48, 2020 Feb 07.
Article
in English
| MEDLINE | ID: mdl-31761948
5.
Sweet-liking is associated with transformation of heavy drinking into alcohol-related problems in young adults with high novelty seeking.
Alcohol Clin Exp Res
; 38(7): 2119-26, 2014 Jul.
Article
in English
| MEDLINE | ID: mdl-24962796
6.
Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis.
JAMA
; 311(18): 1889-900, 2014 May 14.
Article
in English
| MEDLINE | ID: mdl-24825644
7.
Efficacy of acamprosate for alcohol dependence in a family medicine setting in the United States: a randomized, double-blind, placebo-controlled study.
Alcohol Clin Exp Res
; 37(4): 668-74, 2013 Apr.
Article
in English
| MEDLINE | ID: mdl-23134193
8.
Intranasal oxytocin blocks alcohol withdrawal in human subjects.
Alcohol Clin Exp Res
; 37(3): 484-9, 2013 Mar.
Article
in English
| MEDLINE | ID: mdl-23025690
9.
Behavioral counseling after screening for alcohol misuse in primary care: a systematic review and meta-analysis for the U.S. Preventive Services Task Force.
Ann Intern Med
; 157(9): 645-54, 2012 Nov 06.
Article
in English
| MEDLINE | ID: mdl-23007881
10.
Risk and resilience for alcohol use disorder revealed in brain functional connectivity.
Neuroimage Clin
; 32: 102801, 2021.
Article
in English
| MEDLINE | ID: mdl-34482279
11.
Efficacy and tolerability of baclofen in a U.S. community population with alcohol use disorder: a dose-response, randomized, controlled trial.
Neuropsychopharmacology
; 46(13): 2250-2256, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34155332
12.
Efficacy and safety of baclofen for alcohol dependence: a randomized, double-blind, placebo-controlled trial.
Alcohol Clin Exp Res
; 34(11): 1849-57, 2010 Nov.
Article
in English
| MEDLINE | ID: mdl-20662805
13.
Unipolar depression does not moderate responses to the Sweet Taste Test.
Depress Anxiety
; 27(9): 859-63, 2010 Sep.
Article
in English
| MEDLINE | ID: mdl-20336799
14.
Sweet liking and high novelty seeking: independent phenotypes associated with alcohol-related problems.
Alcohol Alcohol
; 45(5): 431-6, 2010.
Article
in English
| MEDLINE | ID: mdl-20663854
15.
The melanocortin system as a potential target for treating alcohol use disorders: A review of pre-clinical data.
Brain Res
; 1730: 146628, 2020 03 01.
Article
in English
| MEDLINE | ID: mdl-31891691
16.
Sweet liking phenotype, alcohol craving and response to naltrexone treatment in alcohol dependence.
Alcohol Alcohol
; 44(3): 293-300, 2009.
Article
in English
| MEDLINE | ID: mdl-19189996
17.
Medications for alcohol use disorders--reply.
JAMA
; 312(13): 1351, 2014 Oct 01.
Article
in English
| MEDLINE | ID: mdl-25268447
18.
Implementation of a Process for Initiating Naltrexone in Patients Hospitalized for Alcohol Detoxification or Withdrawal.
J Hosp Med
; 13(4): 221-228, 2018 04.
Article
in English
| MEDLINE | ID: mdl-29364992
19.
The Use of Baclofen as a Treatment for Alcohol Use Disorder: A Clinical Practice Perspective.
Front Psychiatry
; 9: 708, 2018.
Article
in English
| MEDLINE | ID: mdl-30662411
20.
Reduction in heavy drinking as a treatment outcome in alcohol dependence.
J Subst Abuse Treat
; 33(1): 71-80, 2007 Jul.
Article
in English
| MEDLINE | ID: mdl-17588491